Surgical Robot Cost in 2026: da Vinci Prices vs. the Alternatives

Our analysts compared the da Vinci price ranges in Intuitive's third-quarter 2026 filing with purchase prices that public hospitals in Spain, Portugal, Croatia, England, and India reported for rival systems, and with service and instrument costs, to show what a soft-tissue surgical robot costs a hospital as of Q4 2026.¹

A soft-tissue surgical robot holds instruments and a camera inside the patient while a surgeon controls them from a console. Intuitive's da Vinci has led the market since the early 2000s, and hospitals now have more choices: Medtronic's Hugo, CMR Surgical's Versius, SS Innovations' SSi Mantra, and Distalmotion's DEXTER, which is built for outpatient surgery centers.

Manufacturers quote prices privately, so we used Intuitive's own published ranges, purchase prices that public hospitals and their funders reported, and SS Innovations' reported system sales. Euro, pound, and rupee prices were converted at European Central Bank rates for October 30, 2026.¹³

In the following sections, we compare purchase prices, the running costs of service and instruments, a five-year cost model for one da Vinci, and how widely each system is used.

What a Surgical Robot Costs to Buy

The purchase price is the number a hospital board approves, and public hospitals in Europe often report it when they buy a system with public or charitable money.

Source: Robotics Reviewed analysis of Intuitive's Q3 2026 Form 10-Q, hospital and news reports from 2022 to 2026, and SS Innovations' Q2 2026 results.

Source: Intuitive, El Periódico Extremadura, HealthNews, HINA, BBC News, Torbay and South Devon NHS Foundation Trust, Watford Observer, Business Standard, and SS Innovations. Chart: Robotics Reviewed.

Key Findings

• The two Hugo purchases in Spain and Portugal sit inside the da Vinci range, at about $1.9 million to $2.1 million. The Croatian figure of €5.6 million is the reported value of the system and may cover more than the robot.
• English hospitals reported Versius prices of £1 million to £1.4 million. West Hertfordshire's figure covered seven years, which suggests some of these prices include service.⁸
• SSi Mantra is the clear low-price option. Its 2026 average system revenue of about $391,700 is below the bottom of Intuitive's range, though SS Innovations does not yet have FDA clearance.¹⁰

What a Surgical Robot Costs to Run

The robot is only part of the bill. Instruments wear out after a set number of uses, and service contracts renew every year, so running costs keep growing with each case a hospital performs.

Source: Intuitive Surgical, Form 10-Q for the quarter ended September 30, 2026²

Key Findings

• Intuitive earns $900 to $3,700 in instruments and accessories per procedure, depending on the type of surgery and the instruments used.
• Leasing is now the most common way to get a da Vinci. In the first nine months of 2026, 788 systems went out on operating leases, 409 of them on usage-based terms where payments rise with procedure volume.²
• Intuitive is cutting some instrument costs. It extended the number of uses for some core instruments and introduced volume-based pricing to lower the instrument cost per procedure.²

Five-Year Cost of One da Vinci System

Because instruments are paid per case, the yearly cost of a robot depends on how busy it is. We used the average of about 291 procedures per installed da Vinci in the first nine months of 2026, and applied the low end, midpoint, and high end of Intuitive's published ranges.

Source: Robotics Reviewed analysis of Intuitive's Q3 2026 Form 10-Q.²

Source: Intuitive Surgical. Chart: Robotics Reviewed.

Key Findings

• At midpoint prices, one da Vinci costs about $5.84 million over five years, or about $4,010 per procedure before staff, operating room time, and other hospital costs.
• Instruments are the largest item after the first two years. By year five they add up to about $3.35 million, against a midpoint purchase price of $1.85 million.
• The spread is wide. The same model runs from about $2.29 million at the low end of every range to about $9.39 million at the high end, so the configuration and procedure mix matter as much as the list price.

How Widely Each Surgical Robot Is Used

A lower price matters less if a system has few trained surgeons and little clinical data, so we set the price data beside each company's reported installed base and case count.

Source: Intuitive, CMR Surgical, SS Innovations, and MedTech Dive.^2,10,11,12

Key Findings

• Intuitive's installed base of 12,094 systems is many times larger than any rival in this report, and its customers performed about 906,000 da Vinci procedures in the third quarter of 2026 alone.²
• CMR Surgical says Versius has reached 45,000 cases and needs no dedicated operating room, so a hospital can move it between departments and operating rooms.¹¹
• Distalmotion aims DEXTER at ambulatory surgery centers and passed 3,000 cumulative procedures across Europe and the U.S. in the fourth quarter of 2025, according to MedTech Dive.¹²

What Surgical Robot Costs Mean for Hospitals

For most hospitals, the purchase price is the smaller part of the decision. At typical volumes, instruments and service add up to more than the robot over five years, so the cost per procedure and the financing terms deserve as much attention as the sticker price. Usage-based leases shift that risk to the manufacturer when volumes are uncertain.

The alternatives are no longer much cheaper to buy in Europe. Hugo and Versius purchases reported by public hospitals fall inside the da Vinci range, and the real price gap is in India, where SSi Mantra sells for a fraction of a da Vinci. Our reviews of CMR Surgical, Distalmotion, and SS Innovations cover each company's clearances and track record.

So if you are pricing a surgical robot, ask for the full five-year cost at your expected case volume, including instruments, service after the first year, and any minimum-use terms in a lease.